$520 Million is the total value of SECTORAL ASSET MANAGEMENT INC's 118 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 16.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| EVH | Sell | EVOLENT HEALTH INCcl a | $15,937,558 | -3.1% | 491,142 | -16.1% | 3.06% | -3.7% |
| Sell | R1 RCM INC | $14,237,910 | -3.9% | 949,194 | -29.8% | 2.74% | -4.5% | |
| SWAV | Buy | SHOCKWAVE MEDICAL | $13,562,717 | +68.7% | 62,550 | +60.0% | 2.61% | +67.5% |
| UNH | Buy | UNITEDHEALTH GRP INC | $12,322,784 | -8.0% | 26,075 | +3.2% | 2.37% | -8.7% |
| BMRN | Sell | BIOMARIN PHARMAC INC | $12,099,573 | -15.8% | 124,430 | -10.3% | 2.32% | -16.3% |
| RXDX | Sell | PROMETHEUS BIOSCIENC | $11,600,219 | -6.0% | 108,090 | -3.7% | 2.23% | -6.6% |
| APLS | Buy | APELLIS PHARMACEUTIC | $11,377,440 | +44.4% | 172,490 | +13.2% | 2.19% | +43.5% |
| PTCT | Sell | PTC THERAPEUTICS I | $10,974,857 | +26.4% | 226,566 | -0.4% | 2.11% | +25.5% |
| ICLR | Sell | ICON PLC | $10,794,411 | -1.9% | 50,538 | -10.8% | 2.08% | -2.5% |
| HQY | Sell | HEALTHEQUITY INC | $10,765,946 | -28.4% | 183,375 | -24.8% | 2.07% | -28.9% |
| LNTH | Sell | LANTHEUS HLDGS INC | $9,716,239 | +43.7% | 117,687 | -11.3% | 1.87% | +42.7% |
| JNJ | JOHNSON & JOHNSON | $9,625,500 | -12.3% | 62,100 | 0.0% | 1.85% | -12.9% | |
| New | MINERALYS THERAPEUTI | $9,603,229 | – | 613,233 | +100.0% | 1.85% | – | |
| OPCH | Buy | OPTION CARE HEALTH | $9,483,345 | +15.2% | 298,500 | +9.1% | 1.82% | +14.5% |
| NARI | Sell | INARI MED INC | $9,448,875 | -17.8% | 153,043 | -15.3% | 1.82% | -18.3% |
| TMCI | Buy | TREACE MED CONCEPT | $9,230,699 | +123.2% | 366,443 | +103.7% | 1.77% | +121.8% |
| INSM | INSMED INC | $8,799,369 | -14.7% | 516,092 | 0.0% | 1.69% | -15.2% | |
| LLY | Buy | LILLY ELI & CO | $8,161,376 | +21.1% | 23,765 | +29.1% | 1.57% | +20.3% |
| AGLY | Buy | AGILITI INC | $8,153,348 | +0.3% | 510,222 | +2.4% | 1.57% | -0.3% |
| TVTX | Buy | TRAVERE THERAPEUTICS | $8,065,206 | +31.2% | 358,613 | +22.7% | 1.55% | +30.3% |
| RDNT | Buy | RADNET INC | $7,832,713 | +40.1% | 312,933 | +5.4% | 1.50% | +39.1% |
| PRVA | Sell | PRIVIA HEALTH GROUP | $7,739,414 | +6.1% | 280,312 | -12.8% | 1.49% | +5.3% |
| IRTC | Sell | IRHYTHM TECHNOLOGIES | $7,334,638 | -18.5% | 59,136 | -38.5% | 1.41% | -19.1% |
| Buy | AMYLYX PHARMACEUTIC | $7,112,016 | +21.9% | 242,400 | +53.5% | 1.37% | +21.1% | |
| ATRC | Sell | ATRICURE INC | $6,612,601 | -34.2% | 159,532 | -29.6% | 1.27% | -34.7% |
| ALKS | Sell | ALKERMES PLC | $6,514,709 | +7.5% | 231,100 | -0.3% | 1.25% | +6.7% |
| INSP | Buy | INSPIRE MED SYS INC | $6,436,925 | +40.4% | 27,500 | +51.1% | 1.24% | +39.5% |
| PFE | Buy | PFIZER INC | $6,421,920 | -3.1% | 157,400 | +21.6% | 1.23% | -3.8% |
| ABBV | Buy | ABBVIE INC | $6,263,241 | +3.9% | 39,300 | +5.4% | 1.20% | +3.3% |
| ITCI | Sell | INTRA CELLULAR THERA | $6,183,930 | -4.6% | 114,200 | -6.7% | 1.19% | -5.2% |
| THC | TENET HEALTHCARE | $6,031,130 | +21.8% | 101,500 | 0.0% | 1.16% | +21.0% | |
| AXNX | Buy | AXONICS INC | $5,998,872 | +9.5% | 109,950 | +25.4% | 1.15% | +8.7% |
| PRTA | Buy | PROTHENA CORP PLC | $5,949,693 | -14.3% | 122,750 | +6.6% | 1.14% | -14.8% |
| MRK | MERCK & CO INC | $5,851,450 | -4.1% | 55,000 | 0.0% | 1.12% | -4.7% | |
| FOLD | Buy | AMICUS THERAPEUTICS | $5,766,600 | -7.0% | 519,982 | +2.4% | 1.11% | -7.7% |
| DNLI | Buy | DENALI THERAPEUTICS | $5,641,344 | -16.8% | 244,850 | +0.4% | 1.08% | -17.4% |
| ARVN | Sell | ARVINAS INC | $5,603,714 | -31.5% | 205,114 | -14.3% | 1.08% | -32.0% |
| BLU | Buy | BELLUS HEALTH INC | $5,528,369 | +0.5% | 767,829 | +14.8% | 1.06% | -0.1% |
| BPMC | Buy | BLUEPRINT MEDICINES | $5,484,281 | +8.0% | 121,900 | +5.2% | 1.05% | +7.2% |
| GRTX | Buy | GALERA THERAPEUTIC | $5,372,326 | +116.3% | 2,098,565 | +25.9% | 1.03% | +114.8% |
| RCUS | Buy | ARCUS BIOSCIENCES | $5,356,103 | +8.6% | 293,646 | +23.1% | 1.03% | +7.9% |
| ALNY | Buy | ALNYLAM PHARMACUETCL | $5,322,502 | -1.8% | 26,570 | +16.5% | 1.02% | -2.5% |
| AMGN | Buy | AMGEN INC | $5,299,160 | +12.6% | 21,920 | +22.3% | 1.02% | +11.7% |
| CTIC | Buy | CTI BIOPHARMA CORP | $5,263,860 | -10.7% | 1,253,300 | +27.8% | 1.01% | -11.2% |
| SBTX | Buy | ARS PHARMACEUTICALS | $5,166,251 | -22.6% | 793,587 | +1.4% | 0.99% | -23.1% |
| BSX | Sell | BOSTON SCIENTIFIC | $5,101,859 | -3.3% | 101,976 | -10.5% | 0.98% | -3.8% |
| KRTX | Buy | KARUNA THERAPEUTICS | $4,882,483 | +13.9% | 26,880 | +23.2% | 0.94% | +13.1% |
| New | 2SEVENTY BIO INC | $4,855,200 | – | 476,000 | +100.0% | 0.93% | – | |
| MRTX | Buy | MIRATI THERAPEUTICS | $4,774,135 | +57.6% | 128,406 | +92.1% | 0.92% | +56.7% |
| VERA | New | VERA THERAPEUTICScl a | $4,658,328 | – | 600,300 | +100.0% | 0.90% | – |
| REPL | Buy | REPLIMUNE GROUP INC | $4,630,452 | -13.4% | 262,200 | +33.4% | 0.89% | -13.9% |
| TMO | THERMO FISHER SCI | $4,590,787 | +4.7% | 7,965 | 0.0% | 0.88% | +3.9% | |
| HALO | Sell | HALOZYME THERAPEUTIC | $4,483,506 | -42.7% | 117,400 | -14.6% | 0.86% | -43.0% |
| RAIN | Buy | RAIN ONCOLOGY INC | $4,238,271 | +2718.0% | 484,928 | +2479.4% | 0.82% | +2710.3% |
| ZNTL | Buy | ZENTALIS PHARMACEU | $4,024,800 | -0.6% | 234,000 | +16.4% | 0.77% | -1.1% |
| SGEN | Sell | SEAGEN INC | $3,917,795 | -24.1% | 19,350 | -51.9% | 0.75% | -24.6% |
| IMGN | Buy | IMMUNOGEN INC | $3,845,545 | -3.6% | 1,001,444 | +24.6% | 0.74% | -4.3% |
| SILK | Buy | SILK ROAD MEDICAL | $3,740,398 | -16.3% | 95,589 | +13.0% | 0.72% | -16.9% |
| BIIB | Sell | BIOGEN INC | $3,614,946 | -2.2% | 13,002 | -2.6% | 0.70% | -2.8% |
| ABT | Buy | ABBOTT LABS | $3,569,212 | +2.4% | 35,248 | +11.0% | 0.69% | +1.8% |
| ARQT | Buy | ARCUTIS BIOTHERAPE | $3,488,672 | +15.6% | 317,152 | +55.6% | 0.67% | +14.9% |
| BMY | BRISTOL MYERS SQUIBB | $3,465,500 | -3.7% | 50,000 | 0.0% | 0.67% | -4.3% | |
| OLMA | Sell | OLEMA PHARMACEUTICAL | $3,455,804 | -2.2% | 995,909 | -30.9% | 0.66% | -2.9% |
| SRPT | Buy | SAREPTA THERAPEUTICS | $3,405,779 | +838.7% | 24,710 | +782.5% | 0.66% | +835.7% |
| OM | Buy | OUTSET MED INC | $3,385,600 | -6.3% | 184,000 | +31.4% | 0.65% | -6.9% |
| XBI | Buy | SPDR SER TRs&p biotech | $3,303,932 | +157.1% | 43,353 | +180.0% | 0.64% | +155.0% |
| RCKT | ROCKET PHARMACEUTICA | $3,268,233 | -12.5% | 190,790 | 0.0% | 0.63% | -13.1% | |
| IQV | Buy | IQVIA HOLDINGS INC | $3,241,907 | +4.8% | 16,300 | +7.9% | 0.62% | +4.0% |
| MDT | Buy | MEDTRONIC PLC | $3,228,912 | +31.7% | 40,051 | +26.9% | 0.62% | +30.7% |
| Sell | RALLYBIO CORP | $3,151,560 | -22.6% | 551,937 | -11.0% | 0.61% | -23.1% | |
| ALHC | Sell | ALIGNMENT HEALTHCA | $2,995,560 | -53.6% | 471,000 | -14.2% | 0.58% | -53.9% |
| CYTK | Buy | CYTOKINETICS INC | $2,950,682 | -22.8% | 83,850 | +0.5% | 0.57% | -23.4% |
| DHR | DANAHER CORP | $2,929,965 | -5.0% | 11,625 | 0.0% | 0.56% | -5.7% | |
| MRNA | MODERNA INC | $2,721,130 | -14.5% | 17,718 | 0.0% | 0.52% | -15.1% | |
| EW | EDWARDS LIFESCIENCE | $2,639,087 | +10.9% | 31,900 | 0.0% | 0.51% | +10.0% | |
| REGN | Buy | REGENERON PHARMCTCLS | $2,292,459 | +17.2% | 2,790 | +3.0% | 0.44% | +16.7% |
| RETA | New | REATA PHARMACEUTICcl a | $2,273,000 | – | 25,000 | +100.0% | 0.44% | – |
| PCVX | VAXCYTE INC | $2,248,800 | -21.8% | 60,000 | 0.0% | 0.43% | -22.4% | |
| GILD | Sell | GILEAD SCIENCES INC | $2,132,329 | -4.7% | 25,700 | -1.3% | 0.41% | -5.3% |
| VRTX | Sell | VERTEX PHARMACEUTICL | $2,085,448 | +2.9% | 6,619 | -5.7% | 0.40% | +2.3% |
| ALT | Buy | ALTIMMUNE INC | $2,021,802 | -64.1% | 479,100 | +39.9% | 0.39% | -64.3% |
| BEAM | BEAM THERAPEUTICS | $1,944,370 | -21.7% | 63,500 | 0.0% | 0.37% | -22.2% | |
| HUM | HUMANA INC | $1,735,520 | -5.2% | 3,575 | 0.0% | 0.33% | -5.6% | |
| GBIO | Buy | GENERATION BIO CO | $1,655,801 | +53.9% | 385,070 | +40.6% | 0.32% | +52.9% |
| BCAB | Buy | BIOATLA INC | $1,455,264 | +27.6% | 543,009 | +292.6% | 0.28% | +26.7% |
| MRSN | New | MERSANA THERAPEUTI | $1,410,055 | – | 343,079 | +100.0% | 0.27% | – |
| AZN | ASTRAZENECAsp adr | $1,388,894 | +2.4% | 20,010 | 0.0% | 0.27% | +1.5% | |
| FDMT | Buy | 4D MOLECULAR THERA | $1,375,699 | +15.1% | 80,029 | +48.7% | 0.26% | +14.3% |
| PNT | Sell | POINT BIOPHARMA GBL | $1,327,996 | -1.7% | 182,668 | -1.4% | 0.26% | -2.3% |
| AVIR | Buy | ATEA PHARMACEUTICALS | $1,275,848 | -5.7% | 380,850 | +35.3% | 0.24% | -6.5% |
| ANNX | New | ANNEXON INC | $1,258,203 | – | 326,806 | +100.0% | 0.24% | – |
| ITOS | Buy | ITEOS THERAPEUTICS | $1,202,757 | +6.6% | 88,373 | +53.0% | 0.23% | +6.0% |
| PMVP | New | PMV PHARMACEUTICALS | $1,194,737 | – | 250,469 | +100.0% | 0.23% | – |
| BGNE | Sell | BEIGENE LIMITEDsp adr | $1,187,570 | -9.7% | 5,510 | -7.9% | 0.23% | -10.6% |
| Sell | EXSCIENTIA PLCads | $1,114,606 | -21.1% | 210,303 | -20.7% | 0.21% | -21.6% | |
| SRRK | Sell | SCHOLAR ROCK HLDG | $1,076,552 | -21.3% | 134,569 | -11.0% | 0.21% | -21.9% |
| ILMN | Sell | ILLUMINA INC | $1,051,126 | +12.5% | 4,520 | -2.2% | 0.20% | +11.6% |
| EFFECTOR THERAPEUTCS | $840,359 | -17.5% | 2,382,644 | 0.0% | 0.16% | -17.8% | ||
| HZNP | Sell | HORIZON THERAPEUTICS | $643,926 | -16.8% | 5,900 | -13.2% | 0.12% | -17.3% |
| INCY | INCYTE CORPORATION | $482,764 | -10.0% | 6,680 | 0.0% | 0.09% | -10.6% | |
| SNY | SANOFIspon ads | $484,338 | +12.4% | 8,900 | 0.0% | 0.09% | +12.0% | |
| LEGN | Buy | LEGEND BIOTECH CORPspon ads | $482,200 | +7.3% | 10,000 | +11.1% | 0.09% | +6.9% |
| RDY | Sell | DR REDDYS LABS LTDadr | $455,668 | -12.0% | 8,004 | -20.0% | 0.09% | -12.0% |
| RPRX | ROYALTY PHARMA PLC | $448,213 | -8.8% | 12,440 | 0.0% | 0.09% | -9.5% | |
| UTHR | UNITED THERAPEUTICS | $406,487 | -19.5% | 1,815 | 0.0% | 0.08% | -20.4% | |
| ZLAB | Sell | ZAI LAB LTDadr | $396,526 | -3.8% | 11,922 | -11.2% | 0.08% | -5.0% |
| BNTX | BIONTECH SEspon ads | $336,339 | -17.1% | 2,700 | 0.0% | 0.06% | -16.7% | |
| ARGX | Sell | ARGENX SEsp adr | $316,693 | -10.1% | 850 | -8.6% | 0.06% | -10.3% |
| JAZZ | Buy | JAZZ PHARMA PLC | $317,536 | +1.2% | 2,170 | +10.2% | 0.06% | 0.0% |
| NBIX | NEUROCRINE BIOSCIENC | $283,416 | -15.3% | 2,800 | 0.0% | 0.05% | -16.9% | |
| FUSN | FUSION PHARMACEUTI | $216,010 | +19.7% | 57,297 | 0.0% | 0.04% | +20.0% | |
| MEDP | MEDPACE HOLDINGS | $182,409 | -11.5% | 970 | 0.0% | 0.04% | -12.5% | |
| ASND | ASCENDIS PHARMA A Ssp adr | $181,202 | -12.2% | 1,690 | 0.0% | 0.04% | -12.5% | |
| ROIVANT SCIENCES LTD | $154,980 | -7.6% | 21,000 | 0.0% | 0.03% | -6.2% | ||
| MDGL | New | MADRIGAL PHARMACEUTI | $121,130 | – | 500 | +100.0% | 0.02% | – |
| NVCR | Buy | NOVOCURE LTD | $105,245 | -10.3% | 1,750 | +9.4% | 0.02% | -13.0% |
| NTLA | Sell | INTELLIA THERAPEUT | $92,430 | -96.3% | 2,480 | -96.5% | 0.02% | -96.3% |
| SMMT | New | SUMMIT THERAPEUTICS | $35,000 | – | 20,000 | +100.0% | 0.01% | – |
| CRSP | Exit | CRISPR THERAPEUTICSnamen akt | $0 | – | -2,490 | -100.0% | -0.02% | – |
| GH | Exit | GUARDANT HEALTH INC | $0 | – | -4,770 | -100.0% | -0.02% | – |
| IONS | Exit | IONIS PHARMACEUTICAL | $0 | – | -4,450 | -100.0% | -0.03% | – |
| BTAI | Exit | BIOXCEL THERAPEUTI | $0 | – | -61,156 | -100.0% | -0.25% | – |
| MGNX | Exit | MACROGENICS INC | $0 | – | -200,220 | -100.0% | -0.26% | – |
| Exit | ZYMEWORKS INC | $0 | – | -192,124 | -100.0% | -0.29% | – | |
| FATE | Exit | FATE THERAPEUTICS | $0 | – | -183,000 | -100.0% | -0.36% | – |
| STAA | Exit | STAAR SURGICAL CO | $0 | – | -44,000 | -100.0% | -0.41% | – |
| SYK | Exit | STRYKER CORP | $0 | – | -9,300 | -100.0% | -0.44% | – |
| ARWR | Exit | ARROWHEAD PHARMACEUT | $0 | – | -95,400 | -100.0% | -0.75% | – |
| EXEL | Exit | EXELIXIS INC | $0 | – | -553,475 | -100.0% | -1.72% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-12
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOMARIN PHARMAC INC | 42 | Q3 2023 | 6.7% |
| PTC THERAPEUTICS INC | 42 | Q3 2023 | 2.7% |
| DR REDDYS LABS LTD | 42 | Q3 2023 | 2.0% |
| GILEAD SCIENCES INC | 38 | Q3 2023 | 8.4% |
| INCYTE CORPORATION | 38 | Q3 2023 | 5.2% |
| VERTEX PHARMACEUTICL | 38 | Q3 2023 | 6.0% |
| AMICUS THERAPEUTICS INC | 37 | Q3 2023 | 6.6% |
| PFIZER INC | 35 | Q3 2023 | 6.3% |
| MERCK & CO. INC | 34 | Q3 2023 | 6.4% |
| MEDTRONIC PLC | 33 | Q3 2023 | 4.4% |
View SECTORAL ASSET MANAGEMENT INC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aprea Therapeutics, Inc. | February 12, 2021 | 163,681 | 0.8% |
| LA JOLLA PHARMACEUTICAL CO | February 13, 2020 | ? | ? |
| COLLEGIUM PHARMACEUTICAL, INC | February 13, 2018 | 1,426,862 | 4.4% |
| Advaxis, Inc. | February 10, 2017 | 690,074 | 1.7% |
| AMICUS THERAPEUTICS INC | February 10, 2017 | 5,100,198 | 3.6% |
| OncoMed Pharmaceuticals Inc | February 12, 2016 | ? | ? |
| IRONWOOD PHARMACEUTICALS INC | February 13, 2015 | ? | ? |
| SEQUENOM INC | February 12, 2014 | ? | ? |
| INCYTE CORP | February 11, 2014 | 1,185,260 | 0.7% |
| INTERMUNE INC | February 11, 2014 | ? | ? |
View SECTORAL ASSET MANAGEMENT INC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-02-13 |
| SC 13G | 2023-02-13 |
| 13F-HR | 2023-02-10 |
| 13F-HR | 2022-11-10 |
View SECTORAL ASSET MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.